$1.4 Billion is the total value of Bronte Capital Management Pty Ltd.'s 21 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 23.5% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRcall | $333,643,000 | +52.7% | 144,400 | +46.7% | 23.79% | -4.0% |
| SPY | Buy | SPDR S&P 500 ETF TRcall | $224,759,000 | +471.4% | 52,300 | +428.3% | 16.03% | +259.2% |
| IWO | Buy | ISHARES TRcall | $161,923,000 | +207.7% | 519,500 | +196.9% | 11.55% | +93.4% |
| GOOGL | Buy | ALPHABET INC-CL Acap stk cl a | $120,077,000 | +20.1% | 49,176 | +1.4% | 8.56% | -24.5% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $118,846,000 | +26.3% | 2,253,861 | +6.3% | 8.47% | -20.6% |
| BRKB | Sell | BERKSHIRE HATHAWAY INC-CL Bcl b new | $117,836,000 | +7.8% | 423,993 | -0.9% | 8.40% | -32.2% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $65,611,000 | +133.5% | 117,469 | +97.8% | 4.68% | +46.8% |
| IBKR | Sell | INTERACTIVE BROKERS GRO-CL A | $56,013,000 | -10.2% | 852,162 | -0.2% | 3.99% | -43.5% |
| V | Sell | VISA INC-CLASS A SHARES | $41,489,000 | -6.4% | 177,440 | -15.2% | 2.96% | -41.2% |
| CTVA | Sell | CORTEVA INC | $36,511,000 | -5.0% | 823,242 | -0.2% | 2.60% | -40.3% |
| BK | Sell | BANK OF NEW YORK MELLON CORP | $25,507,000 | +8.2% | 497,891 | -0.2% | 1.82% | -32.0% |
| STT | Sell | STATE STREET CORP | $22,098,000 | -2.2% | 268,574 | -0.2% | 1.58% | -38.5% |
| GOOG | Sell | ALPHABET INC-CL Ccap stk cl c | $17,474,000 | +20.8% | 6,972 | -0.3% | 1.25% | -24.1% |
| BYND | New | BEYOND MEAT INCput | $15,749,000 | – | 100,000 | +100.0% | 1.12% | – |
| GHC | Buy | GRAHAM HOLDINGS CO-CLASS B | $14,892,000 | +89.9% | 23,493 | +68.5% | 1.06% | +19.5% |
| MO | Sell | ALTRIA GROUP INC | $13,711,000 | -6.9% | 287,561 | -0.1% | 0.98% | -41.5% |
| NEM | Sell | NEWMONT CORP | $4,616,000 | -41.7% | 72,829 | -44.6% | 0.33% | -63.4% |
| MDLZ | New | MONDELEZ INTERNATIONAL INC-Acl a | $4,359,000 | – | 69,807 | +100.0% | 0.31% | – |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $3,507,000 | +1.4% | 548,836 | -0.3% | 0.25% | -36.2% |
| BNTX | New | BIONTECH SE-ADRsponsored ads | $2,454,000 | – | 10,963 | +100.0% | 0.18% | – |
| DBTX | New | DECIBEL THERAPEUTICS INC | $1,371,000 | – | 159,462 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.